We are proud to announce two new investments to biomedicine startups. The first is going to Cytokine, which develops a breakthrough and 100% biological treatment for osteoarthritis (a chronic disease of joins) that affects millions of people worldwide. The second one is going to Lyopor, a 3D collagen scaffold for 3D cell culture. It is suitable for testing the behaviour of a wide range of cells in their natural 3D environment, mimicking extracellular matrix and reducing expensive laboratory time.
Read more about on CzechCrunch.
